|
市場調査レポート
商品コード
1397683
乳児保育器の世界市場規模、シェア、産業動向分析レポート:製品別、用途別、エンドユーザー別、地域別展望と予測、2023年~2030年Global Infant Incubator Market Size, Share & Industry Trends Analysis Report By Product (Normal Incubator, Transport Incubator, and Hybrid Incubator), By Application, By End User, By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
乳児保育器の世界市場規模、シェア、産業動向分析レポート:製品別、用途別、エンドユーザー別、地域別展望と予測、2023年~2030年 |
出版日: 2023年12月15日
発行: KBV Research
ページ情報: 英文 338 Pages
納期: 即納可能
![]() |
乳児保育器市場規模は、予測期間中にCAGR 6.8%で成長し、2030年には9億4,490万米ドルに達すると予測されます。2022年の市場規模は32万1,900台となり、成長率は7.0%(2019~2022年)となります。
しかし、乳児保育器の初期購入費用は、ヘルスケア機関、特に予算が限られている機関にかなりの財政負担を強いる可能性があります。このことは、小規模の病院、診療所、または資源が限られた環境にある施設が、十分な量の乳児保育器に投資する能力に影響を与える可能性があります。高コストは、新生児医療インフラの整備と維持に影響する可能性があります。これには、新生児集中治療室(NICU)の設置や、モニタリング装置や呼吸補助システムなどのその他の必須機器の調達が含まれます。ヘルスケア施設が効果的な新生児ケアに必要な機器やリソースを提供できない場合、高コストは間接的に患者の転帰に影響を与える可能性があります。以上のような要因が、今後数年間の市場成長の妨げとなると思われます。
製品の展望
製品別では、市場は通常保育器、輸送保育器、ハイブリッド保育器に区分されます。2022年には、通常の保育器セグメントが市場を独占しました。インキュベーターは、汚染のリスクを最小限に抑えるように設計されています。無菌環境を維持するために、HEPAフィルター、空気循環システム、掃除のしやすい表面などの機能を備えていることが多いです。インキュベーターは、タンパク質、ワクチン、その他のバイオベースの製品を生産するための細胞の増殖をサポートし、バイオテクノロジーや製薬研究において重要な役割を果たしています。通常のインキュベーターは、科学、医療、工業の各領域で多様な役割を果たしています。インキュベーターは、研究、生産、ヘルスケアなどの目的で、生体や生物学的試料の成長と開発をサポートするために、制御された安定した環境を提供します。
用途別展望
用途別に見ると、市場は新生児低体温・低出生体重児、黄疸、その他に細分化されます。黄疸セグメントは2022年の市場で大きな収益シェアを獲得しました。黄疸には、特定の波長を発する特殊な光源(通常は青色光または白色光)を組み込むために使用されます。インキュベーターは、乳児の皮膚に光線療法用の光をコントロールしながら照射することができます。これにより、赤ちゃんに害を与えることなく、ビリルビン濃度を下げるために必要な光を確実に照射することができます。黄疸に使用される保育器では、体温、心拍数、酸素飽和度など、赤ちゃんのバイタルサインを追跡するモニタリングシステムが使用されることが多いです。これによりヘルスケアプロバイダーは、光線療法に対する赤ちゃんの反応を注意深く観察することができます。
エンドユーザーの展望
エンドユーザー別では、市場は新生児・小児病院、産科病院、病院に分類されます。2022年には、新生児・小児病院セグメントが市場で最も高い売上シェアを記録しました。新生児、特に未熟児は体温調節に苦労します。NICUでは、管理された安定した温度を維持し、低体温を防ぐのに役立つ暖かい環境を作り出します。このような病棟では、特に未熟児で生まれた新生児や、管理された環境を必要とする複雑な病状を持つ新生児に使用することができます。新生児病院でも小児病院でも、乳児用保育器の使用は新生児や幼児特有のニーズに合わせて行われ、彼らの幸福と回復に不可欠な、支援的で制御された環境を提供します。
地域別展望
地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が市場で最大の収益シェアを獲得しました。北米には、ヘルスケア技術の進歩、確立されたヘルスケアインフラ、新生児ケアへの重点的な取り組みなど、いくつかの要因が影響しています。高度なヘルスケアインフラ、技術革新、規制基準、財源、新生児ケアへの強いコミットメントが組み合わさって、北米における乳児保育器の採用を後押ししています。これらの要因が相まって、この地域のヘルスケア施設では乳児保育器が広く使用されています。
The Global Infant Incubator Market size is expected to reach $944.9 million by 2030, rising at a market growth of 6.8% CAGR during the forecast period. In the year 2022, the market attained a volume of 321.9 thousand units, experiencing a growth of 7.0% (2019-2022).
Technological advancements extend to transport incubators, facilitating the safe transportation of newborns between hospital departments or healthcare facilities. Thus, the Transport Incubator segment acquired $1,60,895.7 thousand in 2022. These innovations include shock absorption systems, advanced monitoring during transit, and improved power management. Technological improvements often include user-friendly interfaces for healthcare professionals. Touchscreen displays, intuitive controls, and automated features enhance infant incubators' ease of use and efficiency. The continuous evolution of technology in neonatal care devices, including infant incubators, contributes significantly to the expansion of the market. Some of the factors impacting the market are the increase in birth rate of premature infants, surge in awareness regarding neonatal care, and high cost of infant incubators.
The global incidence of premature births has been on the rise, influenced by factors such as maternal age, multiple pregnancies (twins, triplets, etc.), lifestyle choices, and underlying health conditions. Premature infants, especially those born very early, often face health challenges due to underdeveloped organs and systems. They may have difficulty regulating body temperature, breathing, and feeding. It provides a controlled and supportive environment that helps address these vulnerabilities. It becomes essential to create a warm and controlled environment, preventing hypothermia and providing optimal conditions for the infant's growth and development. Additionally, Heightened awareness educates healthcare providers and parents about maintaining a controlled environment for newborns, especially premature infants. It creates a stable and regulated space that supports the unique needs of neonates, including temperature control and respiratory support. Knowledgeable healthcare providers and parents are more likely to recognize the signs of hypothermia in newborns and understand the role of incubators in preventing this condition. Expectant parents gain knowledge about the potential challenges faced by premature infants and the importance of having access to neonatal care facilities equipped with advanced technologies like incubators. The surge in awareness regarding neonatal care is a multifaceted driver that positively impacts the market.
However, the initial purchase cost of infant incubators can impose a considerable financial strain on healthcare institutions, especially those with limited budgets. This may affect the ability of smaller hospitals, clinics, or facilities in resource-constrained settings to invest in sufficient quantities of infant incubators. The high cost can impact the development and maintenance of neonatal care infrastructure. This includes establishing neonatal intensive care units (NICUs) and procuring other essential equipment, such as monitoring devices and respiratory support systems. The high cost can indirectly impact patient outcomes if healthcare facilities cannot provide the necessary equipment and resources for effective neonatal care. The above factors will hamper market growth in the coming years.
Product Outlook
On the basis of product, the market is segmented into normal incubators, transport incubators, and hybrid incubators. In 2022, the normal incubator segment dominated the market. Incubators are designed to minimize the risk of contamination. They often include features like HEPA filters, air circulation systems, and easy-to-clean surfaces to maintain a sterile environment. Incubators play a crucial role in biotechnological and pharmaceutical research, supporting the growth of cells to produce proteins, vaccines, and other bio-based products. Normal incubators serve diverse purposes across scientific, medical, and industrial domains. They provide a controlled and stable environment to support the growth and development of living organisms or biological specimens for research, production, or healthcare purposes.
Application Outlook
Based on application, the market is fragmented into neonatal hypothermia & low birth weight, jaundice, and others. The jaundice segment garnered a significant revenue share in the market in 2022. It is used for jaundice to incorporate a specialized light source, typically blue or white light, that emits a specific wavelength. The incubator allows controlled exposure of the infant's skin to the phototherapy light. This ensures the baby receives the necessary light to reduce bilirubin levels without causing harm. Incubators used for jaundice often use monitoring systems to track the baby's vital signs, including temperature, heart rate, and oxygen saturation. This allows healthcare providers to observe the baby's response to phototherapy closely.
End User Outlook
By end user, the market is classified into neonatal & pediatric hospitals, maternity hospitals, and hospitals. In 2022, the neonatal & pediatric hospitals segment registered the highest revenue share in the market. Neonates, especially premature infants, struggle to regulate their body temperature. In the NICU, it maintains a controlled and stable temperature, creating a warm environment that helps prevent hypothermia. In these units, it can be used for newborns, especially those born prematurely or with complex medical conditions that require controlled environments. In both neonatal and pediatric hospitals, the use of infant incubators is tailored to the unique needs of newborns and young children, providing a supportive and controlled environment that is essential for their well-being and recovery.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region generated the largest revenue share in the market. Several factors influence North America, including advancements in healthcare technology, well-established healthcare infrastructure, and a strong emphasis on neonatal care. A combination of advanced healthcare infrastructure, technological innovation, regulatory standards, financial resources, and a strong commitment to neonatal care drives the adoption of infant incubators in North America. These factors collectively contribute to the widespread use of infant incubators in the region's healthcare facilities.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Natus Medical Incorporated (Archimed SAS), Atom Medical Corporation, Phoenix Medical Systems Pvt. Ltd., Dragerwerk AG & Co. KGaA, Inspiration Healthcare Group PLC, Medicor Elektronika Zrt., Fanem Ltda., Koninklijke Philips N.V., Mediprema Group
Market Segments covered in the Report:
By Product (Volume, Thousand Units, USD Million, 2019 to 2030)
By Application (Volume, Thousand Units, USD Million, 2019 to 2030)
By End User (Volume, Thousand Units, USD Million, 2019 to 2030)
By Geography (Volume, Thousand Units, USD Million, 2019 to 2030)
Companies Profiled
Unique Offerings from KBV Research